Background: The objective of this study was to examine prospectively the associations between family functioning at the end of tumor-directed treatment and the health-related quality of life (HRQL) of pediatric brain tumor survivors (PBTSs) approximately 9 months later.
INTRODUCTION
As the pediatric brain tumor survivor (PBTS) population grows, increased attention is being directed toward health-related quality of life (HRQL). Five-year survival rates for children with brain or central nervous system tumors have increased to 73.8% for malignant brain tumors and 96.6% for nonmalignant tumors over the last 30 years due to treatment advances. 1 However, survivors often experience challenges after treatment, including medical, neurocognitive, psychosocial, and behavioral impairments, that negatively impact autonomy. 2 HRQL comprises the broader impact of an illness on aspects of physical, emotional, social, and school functioning 3 and is a key marker of survivorship quality.
Peterson and Drotar's theoretical model of childhood cancer survivorship 4 integrates medical variables and constructs from systems theory 5 PBTS generally have poorer HRQL across multiple domains compared to other childhood cancer survivors or healthy controls 7 due to tumor-and treatment-related late effects. 2, 8, 9 Within PBTS, HRQL is associated with a range of survivor, disease, treatment, and sociodemographic variables. Specifically, executive function difficulties, 8, 10 low IQ, 11 infratentorial tumor site, 12 radiation therapy, and/or chemotherapy 13, 14 are correlated with poorer HRQL for PBTS.
However, findings are mixed regarding the influence of contextual factors, including socioeconomic status and annual household income, on survivor HRQL. 8, 12, 15 Among youth with chronic illness, family functioning has important implications for well-being beyond medical factors. 16 cancer, family functioning predicts psychosocial HRQL over and above treatment variables 17 and a recent meta-analysis underscores associations between better survivor HRQL and positive indices of family functioning. 18 Cross-sectional studies of PBTS also demonstrate positive associations between family functioning and survivor HRQL. 19, 20 Only one study has examined the prospective influence of family functioning on PBTS HRQL indicating a significant gap in knowledge. 12 This study enrolled 35 youth, measured family variables and HRQL at 1, 6, and 12 months after diagnosis, and did not find significant associations between family functioning and later survivor HRQL. This study was limited by relying on parent-reported family functioning and focusing on the first year postdiagnosis. Additional prospective studies documenting the associations between family functioning and survivor outcomes are essential to elucidating whether potentially modifiable family factors are viable targets for interventions seeking to enhance survivor HRQL.
The completion of tumor-directed therapy marks a vulnerable time when families assume primary responsibility for care from medical team. Given the improved survival rate of PBTS and challenges from late effects, it is important to identify early predictors of HRQL in this group. This study examined the prospective influence of family functioning within 5 months of the end of tumor-directed treatment (baseline) on survivor HRQL 9 months later (follow-up). We hypothesized that family functioning at baseline would be positively associated with survivor HRQL at follow-up when controlling for survivor HRQL at baseline and relevant medical and demographic variables.
METHOD

Participants
Participants included 35 PBTS aged 6-16 years and their mothers. Inclusion criteria specified that PBTS (1) received a form of tumor-directed treatment, including any combination of resection, chemotherapy, and radiation therapy, (2) completed all tumor-directed treatment within the previous 5 months, and (3) were expected to live at least 6 months. Exclusion criteria included a history of cogni- Reasons for not participating included "too much going on" (n = 3), scheduling conflicts (n = 9), lack of interest (n = 8), and passive refusal (n = 9). Survivor race, age, and tumor type did not differ between consenting and nonconsenting families. Thirty-five of the 50 survivor/mother dyads who completed baseline assessments completed follow-up assessments approximately 9 months after baseline. Reasons for not completing follow-up included relapse (n = 5), death (n = 2), withdrawal (n = 2), follow-up at outside medical center (n = 1), and passive refusal (n = 5). Disease-related and demographic variables did not differ between those who did and did not complete follow-up visits. At baseline, survivors (51.4% female) were 11.00 years of age (SD = 2.71), 1.44 years (SD = 1.88) from diagnosis, and 2.76 months (SD = 1.32) from the conclusion of tumor-directed therapy. Mothers were 42.23 years old (SD = 5.71) and primarily in a partnered relationship (77.1%). See Table 1 for complete sample characteristics.
Procedure
The current data are part of a larger study that recruited from a pediatric neurooncology program in the northeast United States. All procedures had institutional review board approval and participants provided consent and assent prior to completing study procedures. 
TA B L E 1 Sample characteristics of participants
c Other tumor types include medulloblastoma (n = 3), germinoma (n = 2), craniopharyngioma (n = 1), germ cell tumor (n = 1), meningioma (n = 1), and neurocytoma (n = 1).
McMaster family assessment device 23
The 12-item General Functioning Scale from the family assessment device (FAD) assessed general family functioning. Participants rated how well statements (e.g., "In times of crisis, we can turn to each other for support") described their family on a 4-pont Likert scale ranging from strongly agree to strongly disagree. The FAD generates scores from 1 to 4 with higher scores indicating greater levels of family dysfunction and scores above 2.0 representing poor family functioning. Mothers and survivors age 8 and higher completed the FAD at baseline.
The FAD is considered a "well-established" measure of family functioning and has been used frequently with families of children with a chronic health condition. 24 Alphas were 0.89 for survivors and 0.81 for mothers.
2.3.3
Family management measure 25 The family management measure (FaMM) is a 53-item ques- The FaMM has been shown to be a valid and reliable measure of FLD in families of children with chronic illness. 25 Mothers completed the FaMM at baseline and the Cronbach alpha for the FLD subscale was 0.81.
Statistical power and data analyses
Power analyses revealed that 29-55 participants were needed to detect effect sizes ranging from 0.25-0.50 for multiple regression analyses with three to five predictors. 26 Descriptive analyses were conducted to describe demographic characteristics, tumor-related variables, family functioning, and HRQL. The distribution of scores for primary variables was checked for violations of normality. Preliminary analyses used paired sample t-tests to evaluate differences in mother-and survivor-rated HRQL and one-sample t-tests to com- All data were analyzed using SPSS version 24 with alpha level set to Table 1 was unrelated to survivor-or mother-reported survivor HRQL at follow-up.
TA B L E 2 Mean values for primary variables
RESULTS
Descriptive and preliminary analyses
Correlational analyses
Pearson bivariate correlations (Table 3 ) revealed significant associations between worse survivor-rated family functioning at baseline and lower survivor-and mother-rated survivor HRQL at follow-up. Additionally, greater mother-rated FLD was associated with worse motherrated survivor HRQL at follow-up.
Linear regression analyses 3.3.1 Survivor-rated HRQL
A hierarchical multiple regression ( 
TA B L E 5 Hierarchical regression analysis predicting mother-rated survivor HRQL at follow-up from family variables
Mother-rated survivor HRQL at follow-up
Step 1 with worse family functioning predicting worse survivor-rated HRQL at follow-up, = -0.43, P < 0.01.
Mother-rated HRQL
A second hierarchical multiple regression (Table 5) 
DISCUSSION
Prior research has focused largely on medical and survivor-related solving. 21 Observation-based approaches 24 offer another way to measure this dynamic construct that reduces reporter bias and enhances validity. For example, ratings of families' interactions have been shown to moderate functional impairments in pediatric TBI. 31 The prospective associations between family functioning and survivor HRQL are notable given that they occurred when controlling for baseline HRQL and pertinent medical and demographic factors related to HRQL at follow-up. Future research is needed to replicate these findings and determine the influence of family variables over and above variables not examined in this study, including survivor neurocognitive functioning (e.g., executive functioning). Such research could establish family functioning as an important factor to assess during off-therapy appointments and a potential target for interventions aiming to enhance survivor HRQL.
Both child and mother reports suggest that the HRQL for PBTS was worse compared to community norms, 9 with 34-48% of survivors in the at-risk range. 3 The current sample reported similar HRQL scores to those reported in other studies of pediatric brain tumor populations. 12 Meeske and colleagues 15 found that for PBTS, psy- Such approaches have had success in pediatric TBI. 33 For example, better family adaptation to illness demands earlier in the disease course, including defined roles in managing survivor health and low levels of conflict, might moderate survivor HRQL over time due to being more responsive to survivors' needs. 4 The present study has a number of strengths including a longitudinal design and obtaining multiple perspectives on survivor HRQL and family functioning. However, the findings should be considered in the context of study limitations. First, there was a large time range from baseline to follow-up, though this was unrelated to survivor HRQL at either time point. Second, the participation rate was low, resulting in a relatively small sample that was primarily Caucasian from relatively higher income families with well-educated mothers who tended to be in a partnered relationship. While the sample characteristics represent the population of our cancer center, 34 greater diversity in terms of demographics and family structure would enhance generalizability, particularly since demographics have been associated with PBTS HRQL in prior research 8 and the current study. Additionally, the small sample limited our ability to evaluate the impact of tumor-directed treatment combinations on HRQL. Finally, only 70% of those enrolled completed both visits. Over half of the participants lost to follow-up (n = 8 or 53.3% of those missing) were due to noncontrollable factors, including relapse and death. Multisite studies may facilitate larger and more representative samples.
Overall, findings highlight a significant subset of PBTS experience poor HRQL following tumor-directed therapy and put forward family functioning as a key predictor of HRQL in this population worthy of increased clinical and research attention. Evidence-based screeners and interventions may improve family functioning and HRQL in this vulnerable population. 35 The transition to survivorship may be a period of particular focus, given potential challenges related to returning to "normal" routines and patterns of family interactions.
